Exegenesis Bio (EGB HK): Synthetic Expert Call Transcript (31 Aug 2026)
Liquidity Pressure and Strategic HKEX IPO Resubmission: Following the lapse of its initial January application on July 14, 2026, Exegenesis Bio...
95 Views
IPO Databook: Exegenesis Bio (HK) - Aug 2026
Exegenesis Bio Inc. is a biopharmaceutical company developing gene therapies for neurological and ophthalmic diseases, established in 2019. It...
113 Views
No more insights